Important note: Information in this article was accurate in 1989. The state of the art may have changed since the publication date.
[The cost of care related to AIDS at the Henri Mondor Hospital]
Ann Med Interne (Paris). 1988;139(7):505-7. Unique Identifier : AIDSLINE MED/89226752 Choukroun G; Danic DL; Veninger G; Emam K; Rasle A; Picard C; Sobel A; Unite d'Immunopathologie Clinique, Hopital Henri Mondor,; Creteil.
Abstract:
A retrospective analysis of the cost of hospital care related to AIDS was undertaken at Henri Mondor hospital, Creteil, to prepare the hospital budget for 1988. Eight representative cases of the type of medical care were thoroughly evaluated with inventories of all direct expenses (medico-technical, pharmaceutical, accommodation) incurred between the first hospital admission of each patient and June 1987 or the patient's death. The study comprises 17 hospital stays of over 24 hours or 439 days of diagnosis and treatment. The total daily direct expenditure varied from 979 to 1119 FF/day (depending on whether the drug Zidovudine was used), that is to say an increase of 7 to 23% compared with the previous average daily cost in the same hospital unit (909 FF/day). The density of personnel is lower than recommended for units receiving patients with advanced AIDS. This lack of personnel is responsible for an underevaluation of total cost of about 10%. Should the number of admissions with this disease increase, the hospital personnel budget would suffer the most, even if hospital admission for AIDS continues to substitute for other decreased or abandoned activities and do not therefore appear in total overexpenditure.
Keywords: Acquired Immunodeficiency Syndrome/*ECONOMICS Adult Delivery of Health Care/*ECONOMICS English Abstract France Hospitalization/*ECONOMICS Hospitals, University Human Male Middle Age Retrospective Studies JOURNAL ARTICLE
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.